Today announced that the company has entered into a distribution agreement with Logista Pharma S.

Spain is a key growth market for BRINAVESS and our brand-new romantic relationship with Logista Pharma is among the many steps towards building a successful brand in this country.’ The state-of-the-art processes developed by Logista Pharma will make sure secure and timely fulfillment of BRINAVESS orders to all or any our hospital customers. Financial details of the agreement weren’t disclosed.. Cardiome enters into contract with Logista to distribute BRINAVESS within Spanish market Cardiome Pharma Corp.In addition, the Company use the proceeds of the Series C funding to advance CAL-263, a delta selective PI3K inhibitor, into Phase 2 studies for the treating patients with inflammatory diseases and to advance the company’s preclinical programs. ‘Calistoga Pharmaceuticals offers demonstrated significant improvement in advancing its promising item development pipeline, including two clinical stage programs,’ stated James Topper, M.D., Ph.D., Chairman of the Board of General and Directors Partner with Frazier Health care.